Literature DB >> 18588430

Association of CHRNA2 polymorphisms with overweight/obesity and clinical characteristics in a Korean population.

Jinju Kim1.   

Abstract

BACKGROUND: Genes correlated with nicotine may be important in obesity because of the role of nicotine in food intake.
METHODS: To determine if single nucleotide polymorphisms (SNPs) in the neuronal nicotinic acetylcholine receptor alpha2 subunit gene (CHRNA2) are associated with overweight/obesity, 156 non-obese and 200 overweight/obese Koreans were genotyped for four CHRNA2 SNPs using an Affymetrix Array Chip.
RESULTS: Of four SNPs, only one, rs2043063, was associated with overweight/obesity in the study population (co-dominant, p=0.049; dominant, p=0.027). Associations between the significant SNP and obesity-related clinical characteristics were observed, but these were not significant.
CONCLUSIONS: The CHRNA2 rs2043063 SNP might be a risk factor for overweight/obesity in Koreans. Therefore, further studies are needed to investigate whether mutations or common polymorphisms of the CHRNA2 gene represent a risk factor for obesity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18588430     DOI: 10.1515/CCLM.2008.230

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

1.  A signal peptide missense mutation associated with nicotine dependence alters α2*-nicotinic acetylcholine receptor function.

Authors:  Bhagirathi Dash; Ronald J Lukas; Ming D Li
Journal:  Neuropharmacology       Date:  2014-01-24       Impact factor: 5.250

2.  Pharmacological and immunochemical characterization of alpha2* nicotinic acetylcholine receptors (nAChRs) in mouse brain.

Authors:  Paul Whiteaker; Jennifer A Wilking; Robert W B Brown; Robert J Brennan; Allan C Collins; Jon M Lindstrom; Jim Boulter
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

3.  Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors.

Authors:  Shahrdad Lotfipour; Janet S Byun; Prescott Leach; Christie D Fowler; Niall P Murphy; Paul J Kenny; Thomas J Gould; Jim Boulter
Journal:  J Neurosci       Date:  2013-05-01       Impact factor: 6.167

4.  Associations between variation in CHRNA5-CHRNA3-CHRNB4, body mass index and blood pressure in the Northern Finland Birth Cohort 1966.

Authors:  Marika Kaakinen; Francesca Ducci; Mikko J Sillanpää; Esa Läärä; Marjo-Riitta Järvelin
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

Review 5.  Genetic & epigenetic approach to human obesity.

Authors:  K Rajender Rao; Nirupama Lal; N V Giridharan
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

Review 6.  Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology.

Authors:  Andrea Becchetti; Laura Clara Grandi; Giulia Colombo; Simone Meneghini; Alida Amadeo
Journal:  Brain Sci       Date:  2020-11-25

Review 7.  Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets.

Authors:  Luiz H C Vasconcelos; Iara L L Souza; Lílian S Pinheiro; Bagnólia A Silva
Journal:  Front Pharmacol       Date:  2016-03-30       Impact factor: 5.810

Review 8.  Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment.

Authors:  Wuyi Liu; Ming D Li
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  ScanBious: Survey for Obesity Genes Using PubMed Abstracts and DisGeNET.

Authors:  Svetlana Tarbeeva; Ekaterina Lyamtseva; Andrey Lisitsa; Anna Kozlova; Elena Ponomarenko; Ekaterina Ilgisonis
Journal:  J Pers Med       Date:  2021-03-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.